Solara Active Pharma Sciences - PP Stock Screener | Share Price & Fundamental Analysis
SOLARAPP1
Pharmaceuticals
Share Price BSE
₹273.50
▼
-31.30 (-10.27%)
As of March 30, 2026, the Solara Active Pharma Sciences - PP share price (BSE: SOLARAPP1) is ₹273.50, down 10.27% from the previous close, with shares trading between ₹272.20 and ₹281.00, and a 52-week range of ₹270.00–₹478.90.
Browse SOLARAPP1 cash flow statement to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Solara Active Pharma Sciences - PP Market Cap
₹346.36 Cr.
SOLARAPP1 P/E Ratio (TTM)
-
Solara Active Pharma Sciences - PP P/B Ratio
2.29
EPS (TTM)
-
Dividend Yield
-
Debt to Equity
-
SOLARAPP1 52 Week High
₹478.90
Solara Active Pharma Sciences - PP 52 Week Low
₹270.00
Operating Margin
-
Profit Margin
-
SOLARAPP1 Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
-
Total Equity
-
Solara Active Pharma Sciences - PP Share Price History - Stock Screener Chart
Screen SOLARAPP1 historical share price movements with interactive charts. Analyze price trends and patterns.
Solara Active Pharma Sciences - PP Company Profile - Fundamental Screener
Screen Solara Active Pharma Sciences - PP company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SOLARAPP1 shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
IN9624Z01022
Solara Active Pharma Sciences - PP Balance Sheet Screener
Screen SOLARAPP1 balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
Solara Active Pharma Sciences - PP Income Statement Screener - Profit & Revenue Analysis
Screen Solara Active Pharma Sciences - PP income statement and profit fundamentals.
Analyze SOLARAPP1 quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Solara Active Pharma Sciences - PP share price evaluation.
Solara Active Pharma Sciences - PP Cash Flow Screener - Liquidity Fundamentals
Screen SOLARAPP1 cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
Solara Active Pharma Sciences - PP Shareholding Pattern Screener
See Solara Active Pharma Sciences - PP shareholding pattern with promoter, FII, and DII holdings.
Check Solara Active Pharma Sciences - PP promoter holding and ownership changes for SOLARAPP1 on TickJournal.
Solara Active Pharma Sciences - PP Share Dividend Screener - Share Yield Analysis
Check Solara Active Pharma Sciences - PP dividend history with payout and yield data.
View Solara Active Pharma Sciences - PP dividend details including ex-dates and amounts for SOLARAPP1 stock.
Solara Active Pharma Sciences - PP Stock Index Membership
See which indices include Solara Active Pharma Sciences - PP stock.
Check SOLARAPP1 index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Solara Active Pharma Sciences - PP Market Events Screener - Corporate Actions
Get Solara Active Pharma Sciences - PP corporate actions including splits, bonuses, and buybacks.
Check Solara Active Pharma Sciences - PP stock events that may affect SOLARAPP1 share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 6.67% |
Solara Active Pharma Sciences - PP Competitors Screener - Peer Comparison
Screen SOLARAPP1 competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 430,345 | 39.32 | 54,729 | 9.71% | 10,980 | 56.35 |
| Divis Laboratories | 159,215 | 64.39 | 9,712 | 18.67% | 2,191 | 39.57 |
| Torrent Pharmaceuticals | 144,367 | 64.00 | 11,539 | 6.99% | 1,911 | 49.85 |
| Dr Reddys Laboratories | 106,975 | 19.68 | 33,741 | 16.73% | 5,725 | 49.71 |
| Lupin | 106,653 | 22.98 | 22,910 | 13.74% | 3,306 | 56.95 |
| Cipla | 100,349 | 22.17 | 28,410 | 7.12% | 5,291 | 34.82 |
| Zydus Life Science | 90,229 | 18.09 | 23,511 | 18.55% | 4,615 | 49.23 |
| Mankind Pharma | 84,163 | 46.25 | 12,744 | 20.90% | 2,007 | 44.70 |
| Aurobindo Pharma | 76,329 | 21.80 | 32,346 | 9.43% | 3,484 | 63.55 |
| Alkem Laboratories | 63,902 | 26.83 | 13,458 | 3.70% | 2,216 | 45.83 |
Solara Active Pharma Sciences - PP Company Announcements - News Screener
Screen SOLARAPP1 latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-12 | Closure of Trading Window | - |
| 2026-04-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-10 | General Update - Rights Issue - Second & Final Call | - |
| 2026-04-10 | Corporate Action- Record Date For The Purpose Of Making Second And Final Call For Rights Equity Shares | - |
| 2026-04-04 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-03-10 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-03-10 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-03-04 | Receipt Of Call Money Pursuant To The Second Reminder Notice Issued For Payment Of First Call Money On Rights Shares | - |
| 2026-03-04 | Intimation Regarding The Closure Of Wholly Owned Subsidiary Of The Company In Brazil. | - |
| 2026-02-10 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-02-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-06 | Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended December 31 2025. | - |
| 2026-02-06 | Announcement Under Regulation 30 Of SEBI (LODR) 2015 Regarding The Revision And Adoption Of Policies. | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-06 | Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025 | - |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |